Reinhard Reents

USPTO Granted Patents = 15 (Patent Applications = 8)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 11 (Patent Applications = 12)

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 42(Granted Patents)

Location History:

Basel, CA (US) (2019)
Muenchenstein, CH (2010 - 2020)
Basel, CH (2011 - 2024)

Company Filing History:

Hoffmann-la Roche Inc.

patents

2 out of 168

F. Hoffmann-la Roche Ag

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12440492 - Pharmaceutical compositions comprising AKT protein kinase inhibitors (2025-10-14),

2. 11969426 - Pharmaceutical compositions comprising Akt protein kinase inhibitors (2024-04-30),

3. 11337977 - Pharmaceutical compositions comprising Akt protein kinase inhibitors (2022-05-24),

4. 10870626 - Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds (2020-12-22),

5. 10858324 - Processes for the preparation of pyrimidinylcyclopentane compounds (2020-12-08),

6. 10457648 - Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds (2019-10-29),

7. 10435378 - Processes for the preparation of pyrimidinylcyclopentane compounds (2019-10-08),

8. 9862689 - Processes for the preparation of pyrimidinylcyclopentane compounds (2018-01-09),

9. 9603816 - Process (2017-03-28),

10. 8895729 - Process for making thienopyrimidine compounds (2014-11-25),

11. 8765989 - Process (2014-07-01),

12. 8664403 - Process (2014-03-04),

13. 8143442 - Preparation for a cyclohexanecarboxylic acid derivative and intermediates (2012-03-27),

14. 7872141 - Processes for the manufacture of a pyrrolidine-3,4-dicarboxamide derivative (2011-01-18),

15. 7858823 - Process for cyclohexanecarboxylic acid derivatives (2010-12-28),

Title: Reinhard Reents: Innovator in Pharmaceutical Compositions

Introduction

Reinhard Reents is a notable inventor based in Muenchenstein, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target critical health issues such as cancer. With a total of 14 patents to his name, Reents has established himself as a key figure in medical innovation.

Latest Patents

Among his latest patents, Reinhard Reents has developed pharmaceutical compositions comprising Akt protein kinase inhibitors. These inventions relate to therapeutic compositions that exhibit activity against diseases like cancer. The processes for their preparation and their use as medicaments highlight the potential impact of his work on cancer treatment.

Career Highlights

Reinhard Reents has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his expertise and success as an inventor.

Collaborations

Reinhard has collaborated with notable professionals in his field, including Francis Gosselin and Hans Iding. These partnerships have likely enhanced the quality and reach of his innovative work.

Conclusion

Reinhard Reents is a distinguished inventor whose work in pharmaceutical compositions has the potential to make a significant difference in cancer treatment. His contributions to the field are marked by a commitment to innovation and collaboration.

This text is generated by artificial intelligence and may not be accurate.